Your Biomarkers & Companion Diagnostics Expert Speakers

Guillaume Desachy

Principal Biostatistician

AstraZeneca

Kristiina Rosin

Regulatory Policy & Intelligence Manager

Abbvie

Maria Orr

Head of Precision Medicine Biopharmaceuticals

AstraZeneca

Rob Hastings

Precision Medicine Expert, Cardiovascular, Renal and Metabolism

AstraZeneca

Berit Mikkelsen

Global Market Access Lead, Precision Medicine

LEO Pharma

Clare Balendran

Vice President, Translational Medicine

Novo Nordisk

Joanne Hackett

Chief Commercial Officer

Genomics England

Thomas Kleen

Chief Scientific Officer

Immodulon Therapeutics

Ellie Corigliano

Global Director Medical Affairs, Oncology, Thoracic & Pan Tumor Biomarkers & Diagnostics, Oncology Global Medical Affairs

Merck & Co.

Florian Leiss

Director, Digital Tissue Biomarkers

AstraZeneca

Javier Perez

Director, Precision Medicine Companion Diagnostics

Regeneron

Michael Epstein

Team Leader, Translational Science

Achilles Therapeutics

Astrid Valles-Sanchez

Senior Scientist, Biomarker Lead

uniQure

Caoimhe Vallely-Gilroy

Head of Data Analytics and Strategy for Healthcare, Healthcare Digital and Data

Merck KGaA

Sibylle Hess

Senior Clinical Biomarker Expert, R&D, Translational Medicine & Early Development, Biomarkers & Clinical Bioanalyses (TMED-BCB)

Sanofi

Szilard Voros

Founder & CEO

Global Genomics Group

Andrew Biankin

Regius Professor of Surgery; Director, Wolfson Wohl Cancer Research Centre

University of Glasgow

Christopher Peters

Clinical Senior Lecturer & Consultant Upper GI Surgeon

Imperial College London

Julien Senac

Global Director, IVD Focus Team

TÜV SÜD

Pierre Lao-Sirieix

Associate Director & Diagnostic Expert

AstraZeneca

Fatima Sulaiman

Head, Research & Services

Scleroderma & Raynaud’s UK

Jude O’Donnell

Head, Regulatory Strategy

Almac Diagnostic Services

Lawrence Weiss

Chief Scientific Officer

NeoGenomics Laboratories

Will Green

Project Director

York Health Economics Consortium

Alan Wookey

Global Head, Companion Diagnostics

Q2 Solutions

Guillaume Desachy

Principal Biostatistician

AstraZeneca

Jörg Engelbergs

Scientific-Regulatory Expert Targeted & Personalized Biomedicines

Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines (National Competent Authority responsible for Biomedicines)

Peter Collins

Head, EU Biopharma BD

Guardant Health

Corinne Dannan

Executive Vice President, Pharma BU, Board Member

HalioDx

Kathryn Becker

Head, Global Scientific Affairs, Innovation & Companion Diagnostics

Abbott Molecular

Luca Quagliata

Global Head, Medical Affairs, Clinical NGS & Oncology Division

Thermo Fisher Scientific

Russell Garlick

Chief Scientific Officer

LGC Clinical Diagnostics

Dagmar Albers

Diversity and Inclusion Lead

Pfizer

Mark Roberts

Senior Director, Diagnostics Development

Covance

Michael Schubert

Editor

The Pathologist Journal

Roche Tissue Diagnostics

Avideh Nezeri

Corporate Vice President Clinical Development, Medical & Regulatory Affairs Europe

Novo Nordisk Region Europe

Jacqui Spencer

Managing Director

Anything is Possible

Jane Finch

Quality Assurance Specialist & Diversity, Inclusion and Belonging

Pfizer

Sandra Milan

Senior Director and Group Leader, Portfolio Management & Operations

Genentech Research and Early Development

Claudia Dollins

Head, Executive Director, Global Regulatory Affairs, Translational Medicine & Devices

Merck KGaA

Domenico Merante

Global Clinical Development TA Lead

Vifor Pharma

Marcia Weber

Preclinical Manager

Handl Therapeutics

Patrick D. Grahouan

Legal Director Exports Market, DNP & DTG

GlaxoSmithKline

Christophe Le Tourneau

Senior Medical Oncologist, Head of the Department of Drug Development and Innovation (D3i)

Institut Curie

David Crosby

Head of Prevention & Early Detection Research

Cancer Research UK

Michael Schubert

Editor

The Pathologist Journal

Xavier Solé Acha

Head of Unit of Bioinformatics for Precision Oncology

Catalan Institute of Oncology

Alain Van Gool

Head Translational Metabolic Laboratory, Department Laboratory Medicine

Radboudumc

James Duboff

Strategic Partnerships Director

Genomics England

John Armstrong

Global Head of Discovery

Galderma International

Patrick McGinley

Head of Costing & SLR

Maidstone & Tunbridge Wells NHS Trust

Andreas Stange

Vice President

TÜV SÜD

Dagmar Albers

Diversity & Inclusion Lead UK

Pfizer

Naim Alkhouri

Director, Fatty Liver Program, Vice President of Academic Affairs

Arizona Liver Health

Vincent Mikol

Vincent Mikol

Sanofi

Ejner Moltzen

Advisor, Innovation Fund Denmark, Chair

International Consortium for Personalized Medicine

Lynn Durham

Chief Executive Officer

Stalicla

Rahul Sharma

Vice President, Global People & Organization Head, Technical R&D

Novartis

Seamus Kearney

Chief Executive Officer and Principal Consultant

ARC Regulatory Ltd.

Elena Hernandez Cebrecos

Director Global Talent & Inclusion Business Partner, Global Drug Development

Novartis

Jennifer O’Lear

Director, Chief Diversity Officer, Head of Engagement & Inclusion

Merck Group

Karen Lauxmann

European Sales Lead Contract Manufacturing

Pfizer CentreOne

Megan Lim

Professor of Pathology and Laboratory Medicine, Director of Hematopathology

University of Pennsylvania

Bridget Bannerman

Translational Science, Theoretical Systems Biology & Global health Researcher

MRC Laboratory of Molecular Biology

Hiromasa Mori

Medical Devices Neurology Patient Technology

UCB S.A.

Ian Walker

Vice President, International

Guardant Health

Jinyu Shan

Research Fellow & Chief Scientific Officer

University of Leicester

Chris Rowe

Innovation Lead - Precision Medicine

Innovate UK

Jeffrey Shuster

Director, Companion Diagnostics

Covance by LabCorp

Kristina McGuire

Senior Director and Head of CDx & Lab Operations, Precision Medicine

Regeneron

Mila Glavaski

Data Science & Machine Learning in Medicine

Independent Consultant